TW202311743A - 包含人類化抗體之試劑 - Google Patents

包含人類化抗體之試劑 Download PDF

Info

Publication number
TW202311743A
TW202311743A TW111127964A TW111127964A TW202311743A TW 202311743 A TW202311743 A TW 202311743A TW 111127964 A TW111127964 A TW 111127964A TW 111127964 A TW111127964 A TW 111127964A TW 202311743 A TW202311743 A TW 202311743A
Authority
TW
Taiwan
Prior art keywords
antibody
humanized antibody
humanized
antibodies
crp
Prior art date
Application number
TW111127964A
Other languages
English (en)
Chinese (zh)
Inventor
石川晴登
山本公隆
泉谷憲幸
小笠原大輔
若林雪
Original Assignee
日商電化股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商電化股份有限公司 filed Critical 日商電化股份有限公司
Publication of TW202311743A publication Critical patent/TW202311743A/zh

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
TW111127964A 2021-07-26 2022-07-26 包含人類化抗體之試劑 TW202311743A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021121812 2021-07-26
JP2021-121812 2021-07-26

Publications (1)

Publication Number Publication Date
TW202311743A true TW202311743A (zh) 2023-03-16

Family

ID=85086990

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111127964A TW202311743A (zh) 2021-07-26 2022-07-26 包含人類化抗體之試劑

Country Status (7)

Country Link
US (1) US20250102496A1 (enExample)
EP (1) EP4372009A4 (enExample)
JP (1) JPWO2023008404A1 (enExample)
KR (1) KR20240005839A (enExample)
CN (1) CN117716037A (enExample)
TW (1) TW202311743A (enExample)
WO (1) WO2023008404A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025135074A1 (ja) * 2023-12-18 2025-06-26 デンカ株式会社 標的抗原の測定方法並びにそれに用いる抗体、不溶性粒子及び標的抗原測定用キット

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07260786A (ja) * 1994-03-18 1995-10-13 Tosoh Corp ヒト由来一定領域を有する抗体を使用する免疫測定方法
WO2005058359A2 (en) * 2003-12-15 2005-06-30 Theralogic Gmbh & Co. Kg Method for neutralizing effects of crp for increasing immune reactions to hiv
CA2700701C (en) * 2007-09-26 2020-12-29 Chugai Seiyaku Kabushiki Kaisha Method of modifying isoelectric point of antibody via amino acid substitution in cdr
EP2050764A1 (en) * 2007-10-15 2009-04-22 sanofi-aventis Novel polyvalent bispecific antibody format and uses thereof
JP4657328B2 (ja) * 2008-07-18 2011-03-23 栄研化学株式会社 免疫反応干渉物質の除去方法
KR20110112307A (ko) * 2008-11-25 2011-10-12 앨더 바이오파마슈티컬즈, 인코포레이티드 알부민을 상승시키고 및／또는 ｃｒｐ를 낮추는 ｉｌ­６의 길항제
US11698368B2 (en) 2014-09-17 2023-07-11 Cornell University Identifying status of male fertility by determining sperm capacitation
WO2017133746A1 (en) * 2016-02-05 2017-08-10 Dana Genetic A/S Method for diagnosing and treating cancer using antibodies that bind to c1 inactivator, c reactive protein and/or complement component c4

Also Published As

Publication number Publication date
KR20240005839A (ko) 2024-01-12
CN117716037A (zh) 2024-03-15
EP4372009A1 (en) 2024-05-22
JPWO2023008404A1 (enExample) 2023-02-02
WO2023008404A1 (ja) 2023-02-02
US20250102496A1 (en) 2025-03-27
EP4372009A4 (en) 2025-06-11

Similar Documents

Publication Publication Date Title
US11372001B2 (en) Anti-human IgG4 monoclonal antibody and methods of making and using same
CN103460048B (zh) 使用改进的免疫复合物(ic) elisa来检测抗体
CN115943310A (zh) 用于检测抗sars-cov-2中和抗体的侧向流动装置
AU2018294758A1 (en) Method for measuring serum amyloid A of various animals and reagent for measurement thereof
TW202311743A (zh) 包含人類化抗體之試劑
JP7455947B2 (ja) アデノウイルスの免疫測定方法及び免疫測定器具
CN114729032A (zh) 识别抗rs病毒的抗体、以及使用了该抗体的免疫测定方法及免疫测定仪器
CN111269314A (zh) 一种抗ck18单克隆抗体及其应用
US20230176054A1 (en) Coronavirus assay
KR20220167285A (ko) 아데노바이러스의 면역 측정 방법 및 면역 측정 기구
JP2021524483A (ja) Ｅ型肝炎ウイルスのＯＲＦ２ｉタンパク質に対する特異性を有する抗体及び診断目的のためのその使用
JP7626753B2 (ja) Ｆｃ領域の一部を欠損した抗体を含む試薬
JP2023126867A (ja) アデノウイルスの免疫測定方法及び免疫測定器具
CN118489061A (zh) 检测方法和检测试剂
WO2022050264A1 (ja) 免疫学的測定法
CN115398234A (zh) 肺炎支原体的免疫测定方法和免疫测定仪器
JP7055715B2 (ja) ジカウイルス抗原および抗ジカウイルス抗体を検出するための方法およびキット
JP7157061B2 (ja) ジカウイルスを検出する方法及びキット
JP2025061422A (ja) 標的抗原の測定方法並びにそれに用いる不溶性粒子及び標的抗原測定用キット
JP2024026911A (ja) 標的抗原の測定方法並びにそれに用いる不溶性粒子及び標的抗原測定用キット
KR20220167284A (ko) 아데노바이러스의 면역 측정 방법 및 면역 측정 기구
HK40031146B (zh) 抗人igg4单克隆抗体及利用该抗体的人igg4测定试剂